New Therapies for Reducing Low-Density Lipoprotein Cholesterol
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference93 articles.
1. Statins: a success story involving FDA, academia and industry. Available at: http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SelectionsFromFDLIUpdateSeriesonFDAHistory/ucm082054.htm. Accessed July 25, 2014.
2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;Circulation,2014
3. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);European Association for Cardiovascular Prevention & Rehabilitation;Eur Heart J,2011
4. 2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can J Cardiol,2013
5. Reducing risk in heart disease: an expert guide to clinical practice for secondary prevention of coronary heart disease;National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand,2012
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design and synthesis of atorvastatin derivatives with enhanced water solubility, hepatoselectivity and stability;RSC Medicinal Chemistry;2023
2. Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction;Lipids in Health and Disease;2021-05-27
3. High-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio in early assessment of disease severity and outcome in patients with acute pancreatitis admitted to the ICU;BMC Gastroenterology;2020-05-27
4. To test, or not to test: that is the question for the future of lipoprotein(a);Expert Review of Cardiovascular Therapy;2019-04-03
5. A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab;Journal of the Chinese Medical Association;2019-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3